Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Senti Biosciences Secures $2 Million in Convertible Note Funding
PUBLIC · SNTISep 03, 2026•3 days ago
Amount Raised
$2 Million
Round Type
Convertible Note
South San FranciscoBiotechnology
Investors
Nsg Bio Innovation Fund, L.P.
Description
On September 3, 2026, Senti Biosciences Holdings, Inc. announced the completion of a $2 million funding round through the issuance and sale of Senior Secured Convertible Notes. This funding was obtained from NSG BioInnovation Fund, L.P., as part of an ongoing effort to support its growth and development. The funding is expected to aid Senti Holdings in advancing its innovative therapies.
Company Information
Company
Senti Biosciences
Location
South San Francisco, California, United States
About
Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.
Don't miss Senti Biosciences's next move
Get an email the moment Senti Biosciences raises, hires an exec, or expands, usually minutes after it happens.
South San FranciscoBiotechnology